POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,305 | +35.2% | 257,271 | 0.0% | 0.02% | +33.3% |
| Q2 2023 | $452,797 | -42.9% | 257,271 | 0.0% | 0.01% | -45.5% |
| Q1 2023 | $792,395 | -43.6% | 257,271 | -3.0% | 0.02% | -48.8% |
| Q4 2022 | $1,405,936 | +51.3% | 265,271 | +0.8% | 0.04% | +30.3% |
| Q3 2022 | $929,000 | +38.7% | 263,271 | +1.4% | 0.03% | +43.5% |
| Q2 2022 | $670,000 | -42.4% | 259,571 | +0.0% | 0.02% | -32.4% |
| Q1 2022 | $1,163,000 | -34.2% | 259,491 | 0.0% | 0.03% | -33.3% |
| Q4 2021 | $1,767,000 | -9.7% | 259,491 | -3.3% | 0.05% | -17.7% |
| Q3 2021 | $1,956,000 | -24.0% | 268,290 | +4.5% | 0.06% | -23.5% |
| Q2 2021 | $2,573,000 | +4.9% | 256,772 | +0.0% | 0.08% | -11.0% |
| Q1 2021 | $2,452,000 | – | 256,771 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |